ATE546462T1 - Peptide und derivate vom apl-typ von hsp60 und pharmazeutische zusammensetzungen - Google Patents

Peptide und derivate vom apl-typ von hsp60 und pharmazeutische zusammensetzungen

Info

Publication number
ATE546462T1
ATE546462T1 AT05794474T AT05794474T ATE546462T1 AT E546462 T1 ATE546462 T1 AT E546462T1 AT 05794474 T AT05794474 T AT 05794474T AT 05794474 T AT05794474 T AT 05794474T AT E546462 T1 ATE546462 T1 AT E546462T1
Authority
AT
Austria
Prior art keywords
hsp60
apl
derivatives
pharmaceutical compositions
type peptides
Prior art date
Application number
AT05794474T
Other languages
English (en)
Inventor
Horta Maria Del Carmen Domoenguez
Palomares Gabriel R Padran
Maroen Nelia Lapez
Perez Norailys Lorenzo
Betancourt Ariana Barber
Ndez Garcoea Ariadna Hern
Cordova Vivian Morera
Doeaz Carelia Cosme
Garcoea Nelson J Merino
Bonachea Ariel Vazquez
Alba Jose Suarez
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE546462T1 publication Critical patent/ATE546462T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05794474T 2004-09-24 2005-09-22 Peptide und derivate vom apl-typ von hsp60 und pharmazeutische zusammensetzungen ATE546462T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20040207A CU23504A1 (es) 2004-09-24 2004-09-24 Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas
PCT/CU2005/000008 WO2006032216A2 (es) 2004-09-24 2005-09-22 Peptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas

Publications (1)

Publication Number Publication Date
ATE546462T1 true ATE546462T1 (de) 2012-03-15

Family

ID=40273413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05794474T ATE546462T1 (de) 2004-09-24 2005-09-22 Peptide und derivate vom apl-typ von hsp60 und pharmazeutische zusammensetzungen

Country Status (17)

Country Link
US (2) US8383771B2 (de)
EP (2) EP2371847B1 (de)
JP (1) JP4755649B2 (de)
KR (2) KR101035283B1 (de)
CN (2) CN101935345B (de)
AR (2) AR051928A1 (de)
AT (1) ATE546462T1 (de)
AU (2) AU2005287757B2 (de)
BR (2) BR122018077204B8 (de)
CA (2) CA2581110C (de)
CU (1) CU23504A1 (de)
DK (2) DK2371847T3 (de)
ES (2) ES2445707T3 (de)
MX (1) MX2007003624A (de)
RU (1) RU2361877C2 (de)
WO (1) WO2006032216A2 (de)
ZA (1) ZA200702938B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2450368A1 (de) 2007-01-30 2012-05-09 Epivax, Inc. Regulatorische t-zellen-epitopen sowie zusammensetzungen damit und anwendungen davon
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
JP5781514B2 (ja) * 2009-09-06 2015-09-24 プロトエービー リミテッド Ｈｓｐ６５由来のペプチド６に特異的なヒト化抗体、その方法及び使用
US20110195905A1 (en) * 2009-10-28 2011-08-11 Argentis Pharmaceuticals, Llc Apls for treating arthritis
CU24508B1 (es) * 2017-12-29 2021-04-07 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición farmacéutica que comprende péptido tipo apl
CU20200026A7 (es) * 2020-04-13 2021-11-04 Ct Ingenieria Genetica Biotecnologia Péptido para el tratamiento del síndrome de la tormenta de citocinas
CN111870697B (zh) * 2020-09-18 2022-09-09 山东鲁抗医药股份有限公司 糖类物质在提高apl型衍生肽稳定性中的应用和冻干组合物
KR102333645B1 (ko) 2021-07-27 2021-12-02 (주)문화전기 각도조절이 용이한 엘이디조명시스템
CN115671253B (zh) * 2021-07-30 2024-02-27 河北菲尼斯生物技术有限公司 Se-dr亲和肽在制备治疗风湿疾病的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701163A (nl) 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
NL8703107A (nl) 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
US5773570A (en) 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
GB9419553D0 (en) 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
US6180103B1 (en) 1994-12-21 2001-01-30 Yeda Research And Development Co., Ltd. Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
GB9519737D0 (en) * 1995-09-27 1995-11-29 Peptide Therapeutics Ltd Polypeptides and their use in treatment and prophylaxis of auto-immune
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
US5993803A (en) 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
GB9911772D0 (en) 1999-05-21 1999-07-21 Semmelweis University Of Medic Diagnosis and treatment of atherosclerosis
US20020169302A1 (en) * 1999-08-23 2002-11-14 Genesis Research And Development Corp. Ltd. Compositions isolated from bovine mammary gland and methods for their use
JP2004501061A (ja) * 1999-12-15 2004-01-15 ペプトル・リミテツド 熱ショックタンパク質６０のフラグメントおよびアンタゴニスト
WO2002057795A2 (en) 2001-01-19 2002-07-25 Cambridge Scientific, Inc. Methods of diagnosis and treatment of osteoporosis

Also Published As

Publication number Publication date
DK1803732T3 (da) 2012-05-29
AU2010219312A1 (en) 2010-09-23
BR122018077204B1 (pt) 2020-01-28
EP2371847A1 (de) 2011-10-05
JP4755649B2 (ja) 2011-08-24
US20100144642A1 (en) 2010-06-10
MX2007003624A (es) 2007-06-13
RU2361877C2 (ru) 2009-07-20
ES2386498T3 (es) 2012-08-22
KR101035283B1 (ko) 2011-05-18
EP1803732A2 (de) 2007-07-04
CN101935345A (zh) 2011-01-05
CN101935345B (zh) 2013-12-11
EP2371847B1 (de) 2013-11-20
WO2006032216A2 (es) 2006-03-30
ES2445707T3 (es) 2014-03-04
KR20100028645A (ko) 2010-03-12
EP1803732B1 (de) 2012-02-22
CN101065398A (zh) 2007-10-31
KR101054332B1 (ko) 2011-08-04
AU2005287757B2 (en) 2010-07-29
AU2010219312B2 (en) 2011-10-06
CA2581110C (en) 2013-04-02
US20090171069A1 (en) 2009-07-02
RU2007115411A (ru) 2008-10-27
BRPI0515893A (pt) 2008-08-12
BRPI0515893B1 (pt) 2020-09-15
US8324164B2 (en) 2012-12-04
CA2797769A1 (en) 2006-03-30
CU23504A1 (es) 2010-04-13
BRPI0515893B8 (pt) 2021-05-25
WO2006032216A3 (es) 2007-05-18
KR20070073787A (ko) 2007-07-10
AR051928A1 (es) 2007-02-21
BR122018077204B8 (pt) 2021-07-27
BRPI0515893A8 (pt) 2019-01-02
JP2008514553A (ja) 2008-05-08
CA2797769C (en) 2015-09-15
DK2371847T3 (da) 2014-02-03
CA2581110A1 (en) 2006-03-30
US8383771B2 (en) 2013-02-26
AU2005287757A1 (en) 2006-03-30
CN101065398B (zh) 2012-12-19
AR074924A2 (es) 2011-02-23
ZA200702938B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
DK1988163T3 (da) Hla-a*3303-begrænset wt1 peptid og farmaceutisk sammensætning omfattende det samme
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
EP1513825A4 (de) Antituberkulöses arzneimittel: zusammensetzungen und verfahren
IL222880A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
EP1732581A4 (de) Polypeptidtransduktion und fusogene peptide
NO20055774D0 (no) Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere
ZA200702938B (en) Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions
DK1641820T3 (da) Fra RasGap afledt peptid til selektiv at dræbe kræftceller
ITMI20021684A1 (it) Composizione farmaceutica di peptide nasale
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
PL1890720T3 (pl) Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania
DE602005004039D1 (de) Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
FR2901273B1 (fr) Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
NO20043440L (no) Orodispersibel farmasoytisk sammensetning omfattende ivabradin
ATE497504T1 (de) Aminoderivate von b-homoandrostanen und b- heteroandrostanen
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
IL180209A (en) Pharmaceutical compositions comprising a selective and specific sinus node if current inhibitor and a calcium inhibitor and uses thereof
EP1737479A4 (de) Therapeutische verabreichung des vermischten antiangiogenen peptids c16y
ITMI20042356A1 (it) Composizione farmaceutica orodisperdibile e procedimento per prepararla
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
DK1787653T3 (da) Antitumoral farmaceutisk sammensætning indeholdende polypeptidfragmenter af serralysiner
FR2907681B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des polypeptides ou des peptides.